tiprankstipranks
HCA Healthcare (MX:HCA)
:HCA
Mexico Market
HCA
HCA Healthcare
RESEARCH TOOLSreports

HCA Healthcare (HCA) Ratios

0 Followers

HCA Healthcare Ratios

MX:HCA's free cash flow for Q2 2026 was $0.15. For the 2026 fiscal year, MX:HCA's free cash flow was decreased by $ and operating cash flow was $0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.78 0.83 1.08 1.18 1.38
Quick Ratio
 0.69 0.73 0.97 1.02 1.17
Cash Ratio
 0.05 0.06 0.13 0.07 0.09
Solvency Ratio
 0.17 0.16 0.15 0.15 0.16
Operating Cash Flow Ratio
 0.58 0.77 0.69 0.75 0.86
Short-Term Operating Cash Flow Coverage
 1.37 1.87 2.24 3.89 23.03
Net Current Asset Value
$ -48.72B$ -49.93B$ -42.54B$ -40.22B$ -38.87B
Leverage Ratios
Debt-to-Assets Ratio
 0.81 0.83 0.76 0.74 0.77
Debt-to-Equity Ratio
 -7.42 -8.33 -18.10 -23.60 -14.53
Debt-to-Capital Ratio
 1.16 1.14 1.06 1.04 1.07
Long-Term Debt-to-Capital Ratio
 1.20 1.17 1.07 1.05 1.08
Financial Leverage Ratio
 -9.21 -10.07 -23.81 -31.69 -18.95
Debt Service Coverage Ratio
 1.33 1.51 1.78 2.55 5.47
Interest Coverage Ratio
 5.21 5.32 5.12 4.97 5.21
Debt to Market Cap
 0.52 0.45 0.55 0.54 0.54
Interest Debt Per Share
 229.29 227.32 182.90 160.78 144.44
Net Debt to EBITDA
 3.02 3.15 3.12 3.22 2.96
Profitability Margins
Gross Profit Margin
28.36%41.50%40.62%39.37%38.48%
EBIT Margin
15.59%15.98%14.99%14.84%17.14%
EBITDA Margin
20.30%20.64%19.68%19.58%22.06%
Operating Profit Margin
15.48%15.83%14.94%14.82%15.03%
Pretax Profit Margin
12.65%13.01%12.07%11.86%14.24%
Net Profit Margin
8.77%8.97%8.16%8.07%9.37%
Continuous Operations Profit Margin
10.07%10.29%9.43%9.38%11.35%
Net Income Per EBT
69.29%69.00%67.58%68.02%65.77%
EBT Per EBIT
81.76%82.17%80.81%80.05%94.78%
Return on Assets (ROA)
11.30%11.17%9.68%9.33%10.76%
Return on Equity (ROE)
-112.87%-112.56%-230.49%-295.49%-203.94%
Return on Capital Employed (ROCE)
29.17%26.97%23.79%22.10%21.28%
Return on Invested Capital (ROIC)
19.41%18.53%16.68%16.42%16.66%
Return on Tangible Assets
13.72%13.45%11.66%11.33%13.19%
Earnings Yield
7.35%6.30%7.42%7.11%8.10%
Efficiency Ratios
Receivables Turnover
 6.35 6.96 6.57 6.52 6.77
Payables Turnover
 11.76 9.49 9.80 9.31 8.74
Inventory Turnover
 33.63 26.77 24.12 19.49 17.92
Fixed Asset Turnover
 2.29 2.43 2.24 2.17 2.18
Asset Turnover
 1.29 1.25 1.19 1.16 1.15
Working Capital Turnover Ratio
 -21.10 -97.30 40.24 21.61 15.64
Cash Conversion Cycle
 37.28 27.65 33.48 35.45 32.49
Days of Sales Outstanding
 57.46 52.47 55.58 55.95 53.88
Days of Inventory Outstanding
 10.85 13.63 15.13 18.73 20.37
Days of Payables Outstanding
 31.03 38.45 37.23 39.23 41.75
Operating Cycle
 68.31 66.10 70.71 74.67 74.25
Cash Flow Ratios
Operating Cash Flow Per Share
 49.92 54.77 40.66 34.62 29.35
Free Cash Flow Per Share
 26.91 33.34 21.81 17.21 14.21
CapEx Per Share
 23.01 21.43 18.85 17.42 15.14
Free Cash Flow to Operating Cash Flow
 0.54 0.61 0.54 0.50 0.48
Dividend Paid and CapEx Coverage Ratio
 1.91 2.25 1.89 1.74 1.69
Capital Expenditure Coverage Ratio
 2.17 2.56 2.16 1.99 1.94
Operating Cash Flow Coverage Ratio
 0.23 0.25 0.23 0.23 0.21
Operating Cash Flow to Sales Ratio
 0.14 0.17 0.15 0.15 0.14
Free Cash Flow Yield
6.63%7.14%7.26%6.36%5.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.95 16.31 13.48 14.07 12.35
Price-to-Sales (P/S) Ratio
 1.16 1.42 1.10 1.13 1.16
Price-to-Book (P/B) Ratio
 -14.16 -17.87 -31.06 -41.56 -25.18
Price-to-Free Cash Flow (P/FCF) Ratio
 15.08 14.00 13.76 15.73 16.88
Price-to-Operating Cash Flow Ratio
 8.37 8.52 7.38 7.82 8.18
Price-to-Earnings Growth (PEG) Ratio
 0.57 0.57 0.86 -13.67 -1.28
Price-to-Fair Value
 -14.16 -17.87 -31.06 -41.56 -25.18
Enterprise Value Multiple
 8.73 10.05 8.70 9.01 8.20
Enterprise Value
 138.22B 156.87B 120.92B 114.66B 108.96B
EV to EBITDA
 8.73 10.05 8.70 9.01 8.20
EV to Sales
 1.77 2.07 1.71 1.76 1.81
EV to Free Cash Flow
 23.05 20.39 21.44 24.46 26.40
EV to Operating Cash Flow
 12.43 12.41 11.50 12.16 12.79
Tangible Book Value Per Share
 -61.95 -56.63 -36.88 -32.62 -33.50
Shareholders’ Equity Per Share
 -29.51 -26.12 -9.66 -6.51 -9.53
Tax and Other Ratios
Effective Tax Rate
 0.20 0.21 0.22 0.21 0.20
Revenue Per Share
 350.10 327.68 273.02 238.50 207.45
Net Income Per Share
 30.70 29.40 22.27 19.24 19.44
Tax Burden
 0.69 0.69 0.68 0.68 0.66
Interest Burden
 0.81 0.81 0.81 0.80 0.83
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.21 0.11 0.44 0.45 0.46
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 1.63 1.86 1.58 1.80 1.25
Currency in USD